文献速递主动脉疾病

开窗分支腔内修复胸腹主动脉瘤:肾下主动脉与髂动脉锚定区的疗效差异

Differences in procedural metrics and clinical outcomes among patients treated by fenestrated-branched endovascular repair of thoracoabdominal aortic aneurysms using infrarenal aortic versus iliac sealing zones.
PubMed 文献 · J Vasc Surg · 2021-05-18

本研究基于430例前瞻性非随机研究中的110例胸腹主动脉瘤患者,比较开窗分支腔内修复术使用肾下主动脉锚定区与髂动脉锚定区的结局。

要点

  • 肾下主动脉锚定需满足平行段>3cm、直径18-32mm且无过度血栓或钙化。
  • 肾下主动脉锚定可缩短腔内操作和透视时间并降低辐射暴露。
  • 两组主要不良事件、脊髓损伤及Ib型内漏发生率无显著差异。

核心结论

  • 肾下主动脉与髂动脉锚定区在开窗分支腔内修复术中均安全有效,前提是患者有合适的锚定段。
  • 肾下主动脉锚定具有缩短腔内和透视时间、降低辐射暴露的轻度操作优势。
  • 两组临床结局及Ib型内漏发生无差异。

研究设计与样本

  • 回顾性分析2013至2020年前瞻性非随机研究中的430例连续患者,筛选出110例胸腹主动脉瘤(I-IV extent)行开窗分支腔内修复术。
  • 55例使用肾下主动脉远端锚定,55例使用髂动脉锚定作为对照,按主动脉疾病范围匹配。

主要发现

  • 平均随访24±18个月,每组各1例Ib型内漏(P=1.0);3年免于Ib型内漏率98%±2% vs 97%±3%,免于二次干预率67%±8% vs 67%±8%(P=NS)。

关键数值与推荐

  • 肾下主动脉锚定的最低解剖标准:平行主动脉长度>3cm,直径18-32mm,无过度血栓或钙化。
  • 肾下主动脉锚定组3年肾下主动脉直径平均增大5±3.2mm,无因疾病进展导致的迟发Ib型内漏。

临床怎么用

  • 对于解剖合适的胸腹主动脉瘤患者,开窗分支腔内修复术可优先考虑肾下主动脉作为远端锚定区,以减少操作时间和辐射暴露。
  • 需严格评估肾下主动脉锚定段的长度、直径及血栓钙化情况,不符合标准者应选择髂动脉锚定。

局限性

  • 本研究为前瞻性非随机研究的回顾性分析,样本量有限(110例),可能存在选择偏倚。
  • 髂动脉锚定组男性更多且血清肌酐更高,两组基线存在差异。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: The purpose of the present study was to assess the outcomes of fenestrated-branched endovascular aortic repair (FB-EVAR) using infrarenal aortic vs iliac sealing zones. METHODS: We reviewed the clinical data of 430 consecutive patients enrolled in a prospective nonrandomized study to evaluate FB-EVAR from 2013 to 2020. The outcomes were analyzed for patients with extent I to IV thoracoabdominal aortic aneurysms who had undergone FB-EVAR with distal implantation in the native infrarenal aorta. The minimum anatomic criteria for the use of infrarenal aortic seal was a >3-cm length of parallel aorta with a diameter of 18 to 32 mm without excessive thrombus or calcification. A control group matched for the extent of aortic disease with an iliac artery seal was used to compare the following endpoints: 30-day mortality, major adverse events, freedom from type Ib endoleak (TIbE), freedom from secondary interventions, and changes in the infrarenal aortic diameter. RESULTS: A total of 110 patients (55 men; mean age, 73 ± 8 years) were included in the present study, 55 with an infrarenal aortic distal seal and 55 with the iliac arteries as the sealing zone. Both groups had similar clinical characteristics and aneurysm extent and diameter, except for a greater number of men and higher serum creatinine in the iliac seal group. Technical success was obtained in 106 patients (96%) and was greater for the iliac sealing zone group (100% vs 93%; P = .04). The use of the infrarenal aortic sealing zone was associated with shorter endovascular (148 ± 56 minutes vs 191 ± 61 minutes; P < .001) and fluoroscopy (76 ± 28 minutes vs 96 ± 32 minutes; P < .001) times and lower radiation exposure (cumulative air kerma, 1.4 ± 1.4 Gy vs 2.1 ± 2.0 Gy; P = .02; dose area product, 147 ± 75 Gy ∙ cm2 vs 208 ± 102 Gy ∙ cm2; P = .006). One patient had died (1%) within 30 days. No differences were found in the major adverse events among the patients treated with infrarenal aortic vs iliac sealing zones (22% vs 18%; P = .63), including any spinal cord injury (13% vs 9%; P = .54) and grade 3 spinal cord injury (7% vs 7%; P = 1.0). The mean clinical follow-up was 24 ± 18 months. TIbE occurred in one patient in each group (P = 1.0). The 3-year freedom from TIbE and freedom from secondary intervention rate was 98% ± 2% and 67% ± 8% for the infrarenal aortic seal group and 97% ± 3% and 67% ± 8% for the iliac seal group, respectively (P = NS). Among the patients treated with infrarenal aortic sealing zones, the mean enlargement of the infrarenal aortic diameter was 5 ± 3.2 mm at 3 years. No late TIbE due to disease progression had developed in the infrarenal aorta. CONCLUSIONS: Infrarenal aortic and iliac artery seal zones are safe and effective during FB-EVAR, provided the patients have suitable segments. The use of the infrarenal aortic sealing zone had modest procedural advantages such as shorter endovascular and fluoroscopy times and lower radiation exposure. No differences were found in the clinical outcomes or development of TIbEs.

来源:J Vasc Surg,查看原文。版权归原作者所有。

引用

  1. Barbosa Lima G, Tenorio ER, Marcondes GB, et al. Differences in procedural metrics and clinical outcomes among patients treated by fenestrated-branched endovascular repair of thoracoabdominal aortic aneurysms using infrarenal aortic versus iliac sealing zones. J Vasc Surg. 2021. PMID: 34019993. doi:10.1016/j.jvs.2021.04.048

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。